Condition
Castration Sensitive Prostate Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Castration Sensitive Prostate Cancer clinical trials that are recruiting, at sites in 2 countries (most in United States (3), Canada (1)). By phase: Phase 2 (2), Phase 4 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Castration Sensitive Prostate Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| PSMA-targeted therapy with hormone suppression for low-volume metastatic prostate cancer | Phase 2 | Rochester, Minnesota | Recruiting | Jun 16, 2026 |
| Recurrence-directed therapy with or without 12 months of androgen-deprivation (ELIGARD) for radio-recurrent oligo-metastatic, hormone-sensitive prostate cancer | Phase 2 | Hamilton, Ontario and 4 other locations | Recruiting | Oct 23, 2024 |
| Evaluating the addition of metformin and turmeric for prostate cancer treatment | Phase 1 | Little Rock, Arkansas | Recruiting | Sep 21, 2023 |
| Evaluating PSMA Changes in Prostate Cancer After Hormonal Therapy | Phase 4 | Portland, Oregon | Recruiting | Jun 26, 2023 |
All recruiting trials (4)
-
PSMA-targeted therapy with hormone suppression for low-volume metastatic prostate cancer
This phase II trial tests leuprolide acetate alone versus with 177Lu-PSMA-617 (with or without abiraterone acetate and prednisone) in men with hormone-sensitive, low-volume metastatic prostate cancer.
-
Recurrence-directed therapy with or without 12 months of androgen-deprivation (ELIGARD) for radio-recurrent oligo-metastatic, hormone-sensitive prostate cancer
This will test whether adding 12 months of ELIGARD® (androgen-deprivation therapy) to recurrence-directed radiotherapy helps men with radio-recurrent oligo-metastatic, hormone-sensitive prostate cancer stay progression-free longer.
-
Evaluating the addition of metformin and turmeric for prostate cancer treatment
This study is testing if adding metformin and turmeric to standard prostate cancer treatment helps men feel better and manage their cancer more effectively.
-
Evaluating PSMA Changes in Prostate Cancer After Hormonal Therapy
This study is testing how hormonal therapy changes a specific protein in men with prostate cancer to see if those changes can help doctors understand the cancer better.
Related topics
Quick answers
How many Castration Sensitive Prostate Cancer clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (3 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.